Please use this identifier to cite or link to this item:
https://dspace.uzhnu.edu.ua/jspui/handle/lib/67189| Title: | Expanding the possibilities of using sodium-glucose cotransporter 2 inhibitors in patients with heart failure |
| Authors: | Росул, Мар'яна Михайлівна Блецкан, Мирослава Михайлівна Іваньо, Наталія Вікторівна Рудакова, Світлана Олександрівна |
| Keywords: | heart failure, acute heart failure, sodium-glucose cotransporter 2 (SGLT-2) inhibitors, empagliflozin, dapagliflozin |
| Issue Date: | Mar-2024 |
| Publisher: | ALUNA Publishing |
| Citation: | Мaryana М. Rоsul, Мyroslava М. Bletskan, Nataliya V. Ivano, Svitlana O. Rudakova. Expanding the possibilities of using sodium-glucose cotransporter 2 inhibitors in patients with heart failure/Wiad Lek. 2024;77(3):585-590. doi: 10.36740/WLek202403130 |
| Abstract: | Aim: To study the potential mechanisms of the beneficial cardiovascular effects of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, the possibilities of improving the treatment and prognosis of patients with acute heart failure (HF) during their use. Materials and Methods: The data analysis of literary sources has been conducted regarding the results of existing studies evaluating the clinical benefit and safety of SGLT-2 inhibitors in patients with acute heart failure. Conclusions: The peculiarities of the pharmacological action of SGLT-2 inhibitors and the obtained research results expand the possibilities of using this group of drugs, demonstrating encouraging prospects in improving the prognosis of patients hospitalized with acute heart failure. |
| Type: | Text |
| Publication type: | Стаття |
| URI: | https://dspace.uzhnu.edu.ua/jspui/handle/lib/67189 |
| Appears in Collections: | Наукові публікації кафедри терапії та сімейної медицини |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Maryana Rosul_2024.pdf | Aim: To study the potential mechanisms of the beneficial cardiovascular effects of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, the possibilities of improving the treatment and prognosis of patients with acute heart failure (HF) during their use. Materials and Methods: The data analysis of literary sources has been conducted regarding the results of existing studies evaluating the clinical benefit and safety of SGLT-2 inhibitors in patients with acute heart failure. Conclusions: The peculiarities of the pharmacological action of SGLT-2 inhibitors and the obtained research results expand the possibilities of using this group of drugs, demonstrating encouraging prospects in improving the prognosis of patients hospitalized with acute heart failure. | 903.63 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.